Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11224661 Controlled-release CNP agonists with increased NEP stability

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kennett Sprogøe0

Ulrich Hersel0

Ana Bernhard0

Felix Cleenmann0

Harald Rau0

Thomas Wegge0

Date of Patent

January 18, 2022

0

Patent Application Number

160671110

Date Filed

January 5, 2017

0

Patent Citations

US Patent 10052366 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof

Patent Citations Received

US Patent 12083182 Controlled-release CNP agonists with increased NEP stability

0

Patent Primary Examiner

Jeanette M Lieb

0

Patent abstract

The present invention relates to controlled-release CNP agonists having an at least 5-fold longer degradation half-life in an in vitro NEP degradation assay than the corresponding released CNP agonist, to pharmaceutical compositions comprising said controlled-release CNP agonist, their use and to methods of treatment.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11224661 Controlled-release CNP agonists with increased NEP stability

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.